The Claim
Caffeine, at concentrations up to 50-fold molar excess relative to amyloid-beta, demonstrates no significant inhibition of amyloid-beta or tau fibrillization or oligomerization in vitro, suggesting that caffeine is not the primary compound responsible for coffee’s anti-aggregation effects.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Even when there’s a lot more caffeine than the sticky proteins in the brain, it doesn’t stop those proteins from clumping together — so caffeine probably isn’t the main reason coffee might help prevent brain clumps.
See the scientific wording
Caffeine, at concentrations up to 50-fold molar excess relative to amyloid-beta, shows no significant inhibition of amyloid-beta or tau fibrillization or oligomerization in vitro, indicating that caffeine is not the primary compound responsible for coffee’s anti-aggregation effects.
What the research says
1 studyStudy: Phenylindanes in Brewed Coffee Inhibit Amyloid-Beta and Tau Aggregation
The study found that caffeine in coffee doesn’t stop the harmful protein clumps linked to Alzheimer’s, but other compounds formed when coffee is roasted do. So, caffeine isn’t the main reason coffee might protect the brain.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.